Alzheimer's disease and its treatment by different approaches: A review

S Srivastava, R Ahmad, SK Khare - European Journal of Medicinal …, 2021 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder that impairs mental ability
development and interrupts neurocognitive function. This neuropathological condition is …

[HTML][HTML] Enhancing autophagy in Alzheimer's disease through drug repositioning

M Eshraghi, M Ahmadi, S Afshar, S Lorzadeh… - Pharmacology & …, 2022 - Elsevier
Alzheimer's disease (AD) is one of the biggest human health threats due to increases in
aging of the global population. Unfortunately, drugs for treating AD have been largely …

Blood-brain delivery methods using nanotechnology

DM Teleanu, C Chircov, AM Grumezescu, A Volceanov… - Pharmaceutics, 2018 - mdpi.com
Pathologies of the brain, of which brain cancer, Alzheimer's disease, Parkinson's disease,
stroke, and multiple sclerosis, are some of the most prevalent, and that presently are poorly …

Carbon nanotubes in biomedicine

V Negri, J Pacheco‑Torres, D Calle… - … for Electrochemical and …, 2020 - Springer
Nowadays, biomaterials have become a crucial element in numerous biomedical,
preclinical, and clinical applications. The use of nanoparticles entails a great potential in …

Nanomaterials for the treatment and diagnosis of Alzheimer's disease: an overview

M Bilal, M Barani, F Sabir, A Rahdar, GZ Kyzas - NanoImpact, 2020 - Elsevier
Alzheimer's disease (AD) is a chronic neurodegenerative disorder associated with
dementia. To overcome the limitations of diagnosis and treatment nanotechnology research …

Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease

G Karthivashan, P Ganesan, SY Park, JS Kim… - Drug …, 2018 - Taylor & Francis
In recent years, the incidental rate of neurodegenerative disorders has increased
proportionately with the aging population. Alzheimer's disease (AD) is one of the most …

Lipid-coated MCM-41 mesoporous silica nanoparticles loaded with berberine improved inhibition of acetylcholine esterase and amyloid formation

AK Singh, SS Singh, AS Rathore… - ACS Biomaterials …, 2021 - ACS Publications
Selective permeability of the blood–brain barrier limits effective treatment of
neurodegenerative disorders. In the present study, brain-targeted lipid-coated mesoporous …

Nanoformulations of herbal extracts in treatment of neurodegenerative disorders

SZ Moradi, S Momtaz, Z Bayrami… - … in bioengineering and …, 2020 - frontiersin.org
Nanotechnology is one of the methods that influenced human life in different ways and is a
substantial approach that assists to overcome the multiple limitations of various diseases …

Expatiating the pharmacological and nanotechnological aspects of the alkaloidal drug berberine: current and future trends

T Behl, S Singh, N Sharma, I Zahoor, A Albarrati… - Molecules, 2022 - mdpi.com
Traditionally, herbal compounds have been the focus of scientific interest for the last several
centuries, and continuous research into their medicinal potential is underway. Berberine …

Systematically designed chitosan-coated solid lipid nanoparticles of ferulic acid for effective management of Alzheimer's disease: A preclinical evidence

S Saini, T Sharma, A Jain, H Kaur, OP Katare… - Colloids and Surfaces B …, 2021 - Elsevier
Ferulic acid (FA) is a ubiquitous natural plant bioactive with distinctive promise in
neurodegenerative disorders. However, its therapeutic efficacy gets compromised owing to …